Literature DB >> 29581585

The dTAG system for immediate and target-specific protein degradation.

Behnam Nabet1,2, Justin M Roberts3, Dennis L Buckley3,4, Joshiawa Paulk3,4, Shiva Dastjerdi3, Annan Yang3, Alan L Leggett1, Michael A Erb3, Matthew A Lawlor3, Amanda Souza3,4, Thomas G Scott3, Sarah Vittori3, Jennifer A Perry3, Jun Qi1,5, Georg E Winter3,6, Kwok-Kin Wong7, Nathanael S Gray8,9, James E Bradner10,11,12.   

Abstract

Dissection of complex biological systems requires target-specific control of the function or abundance of proteins. Genetic perturbations are limited by off-target effects, multicomponent complexity, and irreversibility. Most limiting is the requisite delay between modulation to experimental measurement. To enable the immediate and selective control of single protein abundance, we created a chemical biology system that leverages the potency of cell-permeable heterobifunctional degraders. The dTAG system pairs a novel degrader of FKBP12F36V with expression of FKBP12F36V in-frame with a protein of interest. By transgene expression or CRISPR-mediated locus-specific knock-in, we exemplify a generalizable strategy to study the immediate consequence of protein loss. Using dTAG, we observe an unexpected superior antiproliferative effect of pan-BET bromodomain degradation over selective BRD4 degradation, characterize immediate effects of KRASG12V loss on proteomic signaling, and demonstrate rapid degradation in vivo. This technology platform will confer kinetic resolution to biological investigation and provide target validation in the context of drug discovery.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29581585      PMCID: PMC6295913          DOI: 10.1038/s41589-018-0021-8

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  55 in total

1.  Rapid Protein Depletion in Human Cells by Auxin-Inducible Degron Tagging with Short Homology Donors.

Authors:  Toyoaki Natsume; Tomomi Kiyomitsu; Yumiko Saga; Masato T Kanemaki
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

2.  A chemical genetics approach for the functional assessment of novel cancer genes.

Authors:  Qianhe Zhou; Adnan Derti; David Ruddy; Daniel Rakiec; Iris Kao; Michelle Lira; Veronica Gibaja; HoMan Chan; Yi Yang; Junxia Min; Michael R Schlabach; Frank Stegmeier
Journal:  Cancer Res       Date:  2015-03-18       Impact factor: 12.701

3.  DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.

Authors:  Georg E Winter; Dennis L Buckley; Joshiawa Paulk; Justin M Roberts; Amanda Souza; Sirano Dhe-Paganon; James E Bradner
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

4.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

5.  Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells.

Authors:  Jan Krönke; Namrata D Udeshi; Anupama Narla; Peter Grauman; Slater N Hurst; Marie McConkey; Tanya Svinkina; Dirk Heckl; Eamon Comer; Xiaoyu Li; Christie Ciarlo; Emily Hartman; Nikhil Munshi; Monica Schenone; Stuart L Schreiber; Steven A Carr; Benjamin L Ebert
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

6.  Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription.

Authors:  Dwayne A Bisgrove; Tokameh Mahmoudi; Peter Henklein; Eric Verdin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-09       Impact factor: 11.205

7.  BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.

Authors:  Georg E Winter; Andreas Mayer; Dennis L Buckley; Michael A Erb; Justine E Roderick; Sarah Vittori; Jaime M Reyes; Julia di Iulio; Amanda Souza; Christopher J Ott; Justin M Roberts; Rhamy Zeid; Thomas G Scott; Joshiawa Paulk; Kate Lachance; Calla M Olson; Shiva Dastjerdi; Sophie Bauer; Charles Y Lin; Nathanael S Gray; Michelle A Kelliher; L Stirling Churchman; James E Bradner
Journal:  Mol Cell       Date:  2017-06-29       Impact factor: 17.970

8.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.

Authors:  Cole Trapnell; Brian A Williams; Geo Pertea; Ali Mortazavi; Gordon Kwan; Marijke J van Baren; Steven L Salzberg; Barbara J Wold; Lior Pachter
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

9.  Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins.

Authors:  Taavi K Neklesa; Hyun Seop Tae; Ashley R Schneekloth; Michael J Stulberg; Timothy W Corson; Thomas B Sundberg; Kanak Raina; Scott A Holley; Craig M Crews
Journal:  Nat Chem Biol       Date:  2011-07-03       Impact factor: 15.040

10.  Tunable and reversible drug control of protein production via a self-excising degron.

Authors:  Hokyung K Chung; Conor L Jacobs; Yunwen Huo; Jin Yang; Stefanie A Krumm; Richard K Plemper; Roger Y Tsien; Michael Z Lin
Journal:  Nat Chem Biol       Date:  2015-07-27       Impact factor: 15.040

View more
  178 in total

1.  Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo.

Authors:  Sarah A Richman; Liang-Chuan Wang; Edmund K Moon; Uday R Khire; Steven M Albelda; Michael C Milone
Journal:  Mol Ther       Date:  2020-06-11       Impact factor: 11.454

Review 2.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

3.  Acute BAF perturbation causes immediate changes in chromatin accessibility.

Authors:  Sandra Schick; Sarah Grosche; Katharina Eva Kohl; Danica Drpic; Martin G Jaeger; Nara C Marella; Hana Imrichova; Jung-Ming G Lin; Gerald Hofstätter; Michael Schuster; André F Rendeiro; Anna Koren; Mark Petronczki; Christoph Bock; André C Müller; Georg E Winter; Stefan Kubicek
Journal:  Nat Genet       Date:  2021-02-08       Impact factor: 38.330

4.  Peptidic degron for IMiD-induced degradation of heterologous proteins.

Authors:  Vidyasagar Koduri; Samuel K McBrayer; Ella Liberzon; Adam C Wang; Kimberly J Briggs; Hyejin Cho; William G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-25       Impact factor: 11.205

Review 5.  Epigenetic regulation by endogenous metabolite pharmacology.

Authors:  Rhushikesh A Kulkarni; David C Montgomery; Jordan L Meier
Journal:  Curr Opin Chem Biol       Date:  2019-03-15       Impact factor: 8.822

Review 6.  The PROTACtable genome.

Authors:  Melanie Schneider; Chris J Radoux; Andrew Hercules; David Ochoa; Ian Dunham; Lykourgos-Panagiotis Zalmas; Gerhard Hessler; Sven Ruf; Veerabahu Shanmugasundaram; Michael M Hann; Pam J Thomas; Markus A Queisser; Andrew B Benowitz; Kris Brown; Andrew R Leach
Journal:  Nat Rev Drug Discov       Date:  2021-07-20       Impact factor: 84.694

7.  Human cytomegalovirus IE2 drives transcription initiation from a select subset of late infection viral promoters by host RNA polymerase II.

Authors:  Ming Li; Christopher B Ball; Geoffrey Collins; Qiaolin Hu; Donal S Luse; David H Price; Jeffery L Meier
Journal:  PLoS Pathog       Date:  2020-04-06       Impact factor: 6.823

Review 8.  PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future.

Authors:  Mariell Pettersson; Craig M Crews
Journal:  Drug Discov Today Technol       Date:  2019-02-13

9.  Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite.

Authors:  Minervo Perez; Daniel W Bak; Sarah E Bergholtz; Daniel R Crooks; Bhargav Srinivas Arimilli; Youfeng Yang; Eranthie Weerapana; W Marston Linehan; Jordan L Meier
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

Review 10.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.